-
Hepatic Medicine: Evidence and Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Mice with null mutation of Ceacam1 develop nonalcoholic steatohepatitis
Original Research
(1451) Views (470) Full article downloads
Authors: Sumona Ghosh, Meenakshi Kaw, Payal R Patel, et al
Published Date May 2010
Volume 2010:2 Pages 69 - 78
DOI: http://dx.doi.org/10.2147/HMER.S8902
Sumona Ghosh1,2,*, Meenakshi Kaw1,2,*, Payal R Patel1,2, Kelly J Ledford1,2, Thomas A Bowman1,2, Marcia F McInerney1,4, Sandra K Erickson5, Raymond E Bourey1,3, Sonia M Najjar1,2
1Center for Diabetes and Endocrine Research, 2Departments of Physiology and Pharmacology, and of 3Medicine at the University of Toledo College of Medicine, Health Science Campus, Toledo, OH, USA; 4Department of Medicinal and Biological Chemistry at the College of Pharmacy, University of Toledo, Main Campus, Toledo, OH, USA; 5Department of Medicine, University of California, and Veterans Affairs Medical Center, San Francisco, CA, USA; *These authors contributed equally to this work
Abstract: Transgenic liver-specific inactivation of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM1) impairs hepatic insulin clearance and causes hyperinsulinemia, insulin resistance, elevation in hepatic and serum triglyceride levels, and visceral obesity. It also predisposes to nonalchoholic steatohepatitis (NASH) in response to a high-fat diet. To discern whether this phenotype reflects a physiological function of CEACAM1 rather than the effect of the dominant-negative transgene, we investigated whether Ceacam1 (gene encoding CEACAM1 protein) null mice with impaired insulin clearance also develop a NASH-like phenotype on a prolonged high-fat diet. Three-month-old male null and wild-type mice were fed a high-fat diet for 3 months and their NASH phenotype was examined. While high-fat feeding elevated hepatic triglyceride content in both strains of mice, it exacerbated macrosteatosis and caused NASH-characteristic fibrogenic changes and inflammatory responses more intensely in the null mouse. This demonstrates that CEACAM1-dependent insulin clearance pathways are linked with NASH pathogenesis.
Keywords: nonalcoholic steatohepatitis, CEACAM1, high-fat diet, inflammation, apoptosis, fibrosis
Readers of this article also read:
Health literacy and health seeking behavior among older men in a middle-income nation
Optimal management of hepatorenal syndrome in patients with cirrhosis
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Editorial
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Erratum
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Amino acid-responsive Crohn's disease: a case study
- Oropharyngeal Crohn’s disease
- Methylnaltrexone in the treatment of opioid-induced constipation
- Selected luminal mucosal complications of adult celiac disease




